RINDI, LAURA Statistiche
RINDI, LAURA
DIPARTIMENTO DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA
Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa
2024-01-01 Ferretti, C.; Poma, N. V.; Bernardo, M.; Rindi, L.; Cesta, N.; Tavanti, A.; Tascini, C.; Di Luca, M.
Bedaquiline-based all-oral regimen for macrolide-resistant Mycobacterium abscessus pulmonary disease
2023-01-01 Riccardi, N.; Occhineri, S.; Matucci, T.; Marchetti, G.; Rindi, L.; Tiseo, G.; Cirillo, D. M.; Falcone, M.
Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020
2023-01-01 Giannoni, F; Lanni, A; Iacobino, A; Fattorini, L; Ghisetti, V; Mondo, A; Curtoni, A; de Renzi, G; Andreoni, S; Camaggi, A; Piana, F; Marchese, A; Mazzola, E; Torri, S; Cichero, P; Gona, F; Carletti, S; Cirillo, Dm; Borroni, E; Lombardi, A; Libanori, E; D’Inzeo, S; Giagulli, C; Paganini, G; Pinsi, G; Monzillo, V; Barbarini, D; Arosio, M; Farina, C; Peracchi, M; di Santolo, M; Busetti, M; Sartor, A; Picierno, A; Pedrotti, C; Frizzera, E; Tomasi, M; Scarparo, C; Fallico, L; Dal Monte, P; Bisognin, F; Pietrosemoli, P; Denicolò, A; Piersimoni, C; Pocognoli, A; Bartolesi, A; Rindi, L; Parisio, Em; Badolato, Mc; Cenci, E; Mencacci, A; Fioriti, D; Parisi, G; Mazzarelli, A; Nisii, C; Sali, M; Russo, C; Gentile, L; Meledandri, M; Del Giudice, A; Ronga, L; Costa, D; Grimaldi, A; De Nittis, R; Rollo, T; Dodaro, S; Greco, F; Nisticò, S; Vinci, M; Di Naso, C; Aste, A; Masala, L
Specific Cationic Antimicrobial Peptides Enhance the Recovery of Low-Load Quiescent Mycobacterium tuberculosis in Routine Diagnostics
2023-01-01 Bull, T. J.; Munshi, T.; Lopez-Perez, P. M.; Tran, A. C.; Cosgrove, C.; Bartolf, A.; Menichini, M.; Rindi, L.; Parigger, L.; Malanovic, N.; Lohner, K.; Wang, C. J. H.; Fatima, A.; Martin, L. L.; Esin, S.; Batoni, G.; Hilpert, K.
High genetic heterogeneity of Mycobacterium intracellulare isolated from respiratory specimens
2022-01-01 Lari, Nicoletta; Rindi, Laura
LysX2 is a Mycobacterium tuberculosis membrane protein with an extracytoplasmic MprF-like domain
2022-01-01 Boldrin, F.; Cioetto Mazzabo, L.; Laneelle, M. -A.; Rindi, L.; Segafreddo, G.; Lemassu, A.; Etienne, G.; Conflitti, M.; Daffe, M.; Garzino Demo, A.; Manganelli, R.; Marrakchi, H.; Provvedi, R.
Pretomanid for tuberculosis treatment: an update for clinical purposes
2022-01-01 Occhineri, S.; Matucci, T.; Rindi, L.; Tiseo, G.; Falcone, M.; Riccardi, N.; Besozzi, G.
Rapid and Accurate Identification of Nontuberculous Mycobacteria Directly from Positive Primary MGIT Cultures by MALDI-TOF MS
2022-01-01 Rindi, L.; Puglisi, V.; Franconi, I.; Fais, R.; Lupetti, A.
Rapid Molecular Diagnosis of Extra-Pulmonary Tuberculosis by Xpert/RIF Ultra
2022-01-01 Rindi, L.
Rapid identification of nontuberculous mycobacteria directly from positive primary MGIT coltures by MALDI-TOF MS
2021-01-01 Rindi, Laura; Puglisi, Vincenzo; Fais, Roberta; Lupetti, Antonella
Effect of efflux pump inhibitors on the susceptibility of Mycobacterium avium complex to clarithromycin
2020-01-01 Menichini, Melissa; Lari, Nicoletta; Rindi, Laura
Efflux pump inhibitors against nontuberculous mycobacteria
2020-01-01 Rindi, L.
Evaluation of Xpert MTB/RIF Ultra assay for rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an Italian center
2020-01-01 Menichini, M.; Lari, N.; Lupetti, A.; Rindi, L.
Clinical, epidemiological, and genetic features of human Mycobacterium avium, Mycobacterium intracellulare and Mycobacterium chimaera strains isolated in Tuscany, Italy, from 2004 to 2019
2019-01-01 Fonnesu, Rossella; Menichini, Melissa; Lari, Nicoletta; Rindi, Laura
Diagnosi rapida di tubercolosi: valutazione del test Xpert MTB/RIF Ultra in campioni polmonari ed extra-polmonari
2019-01-01 Menichini, Melissa; Rindi, Laura
Lack of circulating toxoplasma gondii DNA in seropositive patients with bipolar or schizophrenia spectrum disorders.
2019-01-01 Galli, L; Del Grande, C; Rindi, L; Mangia, C; Mangano, V; Schiavi, E; Masci, I; Pinto, B; Kramer, L; Dell'Osso, L; Bruschi, F.
Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries
2018-01-01 Cabibbe, Am; Trovato, A; De Filippo, Mr; Ghodousi, A; Rindi, L; Garzelli, C; Baretti, S; Allodi, G; Mannino, R; Rossolini, Gm; Bartoloni, A; Tortoli, E; Cirillo, Dm.
Efficacia degli inibitori di pompe di efflusso in associazione alla claritromicina in isolati clinici di Mycobacterium avium subsp. hominissuis
2018-01-01 Menichini, M.; Rindi, L.
Genetic diversity and drug resistance of Mycobacterium avium in Italy
2018-01-01 Genua, Flavia; Menichini, Melissa; Lari, Nicoletta; Rindi, Laura
Genetic diversity of Mycobacterium avium subsp. hominissuis strains isolated in Italy based on VNTR loci analysis.
2018-01-01 Menichini, Melissa; Genua, Flavia; Lari, Nicoletta; Rindi, Laura
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa | 1-gen-2024 | Ferretti, C.; Poma, N. V.; Bernardo, M.; Rindi, L.; Cesta, N.; Tavanti, A.; Tascini, C.; Di Luca, M. | |
| Bedaquiline-based all-oral regimen for macrolide-resistant Mycobacterium abscessus pulmonary disease | 1-gen-2023 | Riccardi, N.; Occhineri, S.; Matucci, T.; Marchetti, G.; Rindi, L.; Tiseo, G.; Cirillo, D. M.; Falcone, M. | |
| Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020 | 1-gen-2023 | Giannoni, F; Lanni, A; Iacobino, A; Fattorini, L; Ghisetti, V; Mondo, A; Curtoni, A; de Renzi, G; Andreoni, S; Camaggi, A; Piana, F; Marchese, A; Mazzola, E; Torri, S; Cichero, P; Gona, F; Carletti, S; Cirillo, Dm; Borroni, E; Lombardi, A; Libanori, E; D’Inzeo, S; Giagulli, C; Paganini, G; Pinsi, G; Monzillo, V; Barbarini, D; Arosio, M; Farina, C; Peracchi, M; di Santolo, M; Busetti, M; Sartor, A; Picierno, A; Pedrotti, C; Frizzera, E; Tomasi, M; Scarparo, C; Fallico, L; Dal Monte, P; Bisognin, F; Pietrosemoli, P; Denicolò, A; Piersimoni, C; Pocognoli, A; Bartolesi, A; Rindi, L; Parisio, Em; Badolato, Mc; Cenci, E; Mencacci, A; Fioriti, D; Parisi, G; Mazzarelli, A; Nisii, C; Sali, M; Russo, C; Gentile, L; Meledandri, M; Del Giudice, A; Ronga, L; Costa, D; Grimaldi, A; De Nittis, R; Rollo, T; Dodaro, S; Greco, F; Nisticò, S; Vinci, M; Di Naso, C; Aste, A; Masala, L | |
| Specific Cationic Antimicrobial Peptides Enhance the Recovery of Low-Load Quiescent Mycobacterium tuberculosis in Routine Diagnostics | 1-gen-2023 | Bull, T. J.; Munshi, T.; Lopez-Perez, P. M.; Tran, A. C.; Cosgrove, C.; Bartolf, A.; Menichini, M.; Rindi, L.; Parigger, L.; Malanovic, N.; Lohner, K.; Wang, C. J. H.; Fatima, A.; Martin, L. L.; Esin, S.; Batoni, G.; Hilpert, K. | |
| High genetic heterogeneity of Mycobacterium intracellulare isolated from respiratory specimens | 1-gen-2022 | Lari, Nicoletta; Rindi, Laura | |
| LysX2 is a Mycobacterium tuberculosis membrane protein with an extracytoplasmic MprF-like domain | 1-gen-2022 | Boldrin, F.; Cioetto Mazzabo, L.; Laneelle, M. -A.; Rindi, L.; Segafreddo, G.; Lemassu, A.; Etienne, G.; Conflitti, M.; Daffe, M.; Garzino Demo, A.; Manganelli, R.; Marrakchi, H.; Provvedi, R. | |
| Pretomanid for tuberculosis treatment: an update for clinical purposes | 1-gen-2022 | Occhineri, S.; Matucci, T.; Rindi, L.; Tiseo, G.; Falcone, M.; Riccardi, N.; Besozzi, G. | |
| Rapid and Accurate Identification of Nontuberculous Mycobacteria Directly from Positive Primary MGIT Cultures by MALDI-TOF MS | 1-gen-2022 | Rindi, L.; Puglisi, V.; Franconi, I.; Fais, R.; Lupetti, A. | |
| Rapid Molecular Diagnosis of Extra-Pulmonary Tuberculosis by Xpert/RIF Ultra | 1-gen-2022 | Rindi, L. | |
| Rapid identification of nontuberculous mycobacteria directly from positive primary MGIT coltures by MALDI-TOF MS | 1-gen-2021 | Rindi, Laura; Puglisi, Vincenzo; Fais, Roberta; Lupetti, Antonella | |
| Effect of efflux pump inhibitors on the susceptibility of Mycobacterium avium complex to clarithromycin | 1-gen-2020 | Menichini, Melissa; Lari, Nicoletta; Rindi, Laura | |
| Efflux pump inhibitors against nontuberculous mycobacteria | 1-gen-2020 | Rindi, L. | |
| Evaluation of Xpert MTB/RIF Ultra assay for rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an Italian center | 1-gen-2020 | Menichini, M.; Lari, N.; Lupetti, A.; Rindi, L. | |
| Clinical, epidemiological, and genetic features of human Mycobacterium avium, Mycobacterium intracellulare and Mycobacterium chimaera strains isolated in Tuscany, Italy, from 2004 to 2019 | 1-gen-2019 | Fonnesu, Rossella; Menichini, Melissa; Lari, Nicoletta; Rindi, Laura | |
| Diagnosi rapida di tubercolosi: valutazione del test Xpert MTB/RIF Ultra in campioni polmonari ed extra-polmonari | 1-gen-2019 | Menichini, Melissa; Rindi, Laura | |
| Lack of circulating toxoplasma gondii DNA in seropositive patients with bipolar or schizophrenia spectrum disorders. | 1-gen-2019 | Galli, L; Del Grande, C; Rindi, L; Mangia, C; Mangano, V; Schiavi, E; Masci, I; Pinto, B; Kramer, L; Dell'Osso, L; Bruschi, F. | |
| Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries | 1-gen-2018 | Cabibbe, Am; Trovato, A; De Filippo, Mr; Ghodousi, A; Rindi, L; Garzelli, C; Baretti, S; Allodi, G; Mannino, R; Rossolini, Gm; Bartoloni, A; Tortoli, E; Cirillo, Dm. | |
| Efficacia degli inibitori di pompe di efflusso in associazione alla claritromicina in isolati clinici di Mycobacterium avium subsp. hominissuis | 1-gen-2018 | Menichini, M.; Rindi, L. | |
| Genetic diversity and drug resistance of Mycobacterium avium in Italy | 1-gen-2018 | Genua, Flavia; Menichini, Melissa; Lari, Nicoletta; Rindi, Laura | |
| Genetic diversity of Mycobacterium avium subsp. hominissuis strains isolated in Italy based on VNTR loci analysis. | 1-gen-2018 | Menichini, Melissa; Genua, Flavia; Lari, Nicoletta; Rindi, Laura |